Literature DB >> 8864999

Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.

M Maruno1, T Yoshimine, A K Muhammad, K Tokiyoshi, T Hayakawa.   

Abstract

We analyzed 19 samples of various astrocytic tumors (3 astrocytomas, 5 anaplastic astrocytomas, and 11 glioblastomas) for loss of heterozygosity (LOH) on chromosome 9p at 6 microsatellite loci (D9S54, IFNA, D9S171, D9S104, D9S165, and D9S166). Polymerase chain reaction was performed and the products were electrophoresed on polyacrylamide gel. As many as 16 of the 19 samples (84%) exhibited LOH. Three of the 7 informative loci (43%) showed LOH at D9S54, 7 of 17 (41%) at IFNA, 8 of 14 (57%) at D9S171, 7 of 14 (50%) at D9S104, 4 of 8 (50%) at D9S165, and 2 of 7 (29%) at D9S166. LOH was recognized in 57% of the informative loci in anaplastic astrocytomas and 54% in glioblastomas, while it was seen in only 8% of the astrocytomas. Accumulation of LOH with progression or recurrence of tumor was seen in 2 patients. Although, the survival period of the patients correlated well to the histological types of astrocytic tumors, we could not find any obvious correlations between the presence/absence of LOH and the survival period in these patients. In conclusion, we speculate that LOH on chromosome 9p is involved in malignant progression of astrocytomas, but has no significance in predicting survival period in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864999     DOI: 10.1007/bf00177439

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

Review 2.  Molecular genetics of primary intracranial tumors.

Authors:  V P Collins; C D James
Journal:  Curr Opin Oncol       Date:  1990-08       Impact factor: 3.645

3.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.

Authors:  O I Olopade; R B Jenkins; D T Ransom; K Malik; H Pomykala; T Nobori; J M Cowan; J D Rowley; M O Diaz
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.

Authors:  I Orlow; P Lianes; L Lacombe; G Dalbagni; V E Reuter; C Cordon-Cardo
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

5.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia.

Authors:  A Coleman; J W Fountain; T Nobori; O I Olopade; G Robertson; D E Housman; T G Lugo
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

7.  Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.

Authors:  E A Holland; S C Beaton; B G Edwards; R F Kefford; G J Mann
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

8.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

9.  Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.

Authors:  A von Deimling; B Bender; R Jahnke; A Waha; J Kraus; S Albrecht; R Wellenreuther; F Fassbender; J Nagel; A G Menon
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

10.  Frequent genetic instability in small intestinal carcinomas.

Authors:  K Hibi; K Kondo; S Akiyama; K Ito; H Takagi
Journal:  Jpn J Cancer Res       Date:  1995-04
View more
  4 in total

1.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.

Authors:  Gerald F Reis; Melike Pekmezci; Helen M Hansen; Terri Rice; Roxanne E Marshall; Annette M Molinaro; Joanna J Phillips; Hannes Vogel; John K Wiencke; Margaret R Wrensch; Kyle M Walsh; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2015-05       Impact factor: 3.685

3.  Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.

Authors:  Daniel J Brat; Wendy F Seiferheld; Arie Perry; Elizabeth H Hammond; Kevin J Murray; Alan R Schulsinger; Minesh P Mehta; Walter J Curran
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

4.  Loss of Heterozygosity of 9p Is Associated with Poorer Survival in Patients with Gliomas.

Authors:  Tingfen Huang; Shufa Li; Zhen Yang; Jicheng Liu; Yunwei Han
Journal:  Mol Neurobiol       Date:  2015-11-19       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.